GLP-1 for weight loss Medically reviewed by Dr Crystal Wyllie Last reviewed: 19 Jun 2026 Glucagon-like peptide-1 (GLP-1) agonists are a popular weight loss treatment in the UK
The association of the metabolic profile in diabetes mellitus type 2 patients with obsessive-compulsive symptomatology and depressive symptomatology: new insights
Furthermore, insufficient guidance on dietary support limits the effectiveness of treatments, as studies show 60% of patients report a lack of proper nutritional advice from healthcare providers
In America, everything is FDA questioned, Movshovich said
Corticosteroid interactions appear potentially favorable, with BPC-157 counteracting corticosteroid-induced healing impairment in some studies
Patients with pre-existing kidney disease should be particularly vigilant, as dehydration can worsen renal function